1,7-phenanthroline has been researched along with 4-cymene in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barilleau, L; Fosse, C; Haquette, P; Madern, N; Salmain, M; Talbi, B | 1 |
| Aranđelović, S; Gasser, G; Gligorijević, N; Grgurić-Šipka, S; Nikolić, S; Radulović, S; Rangasamy, L | 1 |
| Kuo, YC; Madaan, Y; Mondal, A; Moorthy, A; Paira, P; Roy, N; Sarkar, B | 1 |
| Brabec, V; Kasparkova, J; Kostrhunova, H; Markova, L; Novohradsky, V; Trávníček, Z | 1 |
4 other study(ies) available for 1,7-phenanthroline and 4-cymene
| Article | Year |
|---|---|
Chemically engineered papain as artificial formate dehydrogenase for NAD(P)H regeneration.
Topics: 2,2'-Dipyridyl; Benzene; Cymenes; Ethylenediamines; Formate Dehydrogenases; Monoterpenes; NADP; Organometallic Compounds; Oxidation-Reduction; Papain; Phenanthrolines; Ruthenium | 2011 |
Synthesis, characterization and biological evaluation of novel Ru(II)-arene complexes containing intercalating ligands.
Topics: A549 Cells; Antineoplastic Agents; Cations, Divalent; Cell Line; Cell Line, Tumor; Cell Survival; Cisplatin; Coordination Complexes; Cymenes; Dose-Response Relationship, Drug; G2 Phase Cell Cycle Checkpoints; HeLa Cells; Humans; Intercalating Agents; Monoterpenes; Organometallic Compounds; Phenanthrolines; Phenazines; Ruthenium; S Phase Cell Cycle Checkpoints; Solubility | 2016 |
Luminescent anticancer ruthenium(ii)-p-cymene complexes of extended imidazophenanthroline ligands: synthesis, structure, reactivity, biomolecular interactions and live cell imaging.
Topics: Antineoplastic Agents; Cell Survival; Coordination Complexes; Cymenes; Dose-Response Relationship, Drug; HeLa Cells; Humans; Ligands; Luminescent Agents; Molecular Structure; Optical Imaging; Phenanthrolines; Ruthenium; Structure-Activity Relationship | 2019 |
An anticancer Os(II) bathophenanthroline complex as a human breast cancer stem cell-selective, mammosphere potent agent that kills cells by necroptosis.
Topics: Antineoplastic Agents; Apoptosis; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Chloroacetates; Coordination Complexes; Cymenes; Female; Humans; Necroptosis; Necrosis; Neoplasm Recurrence, Local; Neoplastic Stem Cells; Organoplatinum Compounds; Osmium; Phenanthrolines; Tumor Microenvironment | 2019 |